Publications by authors named "Ping Mahling"

Claim this Profile
A
A phase 2a trial of brepocitinib for cicatricial alopecia.
Eden David, Neda Shokrian, Ester Del Duca, Marguerite Meariman, Celina Dubin, Ping Mahling

J Am Acad Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of PF-07038124 in Patients With Atopic Dermatitis and Plaque Psoriasis: A Randomized Clinical Trial.
Lawrence F Eichenfield, Sanela Tarabar, Seth Forman, Alfonso García-Bello, Gang Feng, Ping Mahling

JAMA Dermatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Characterization and Phase I Study of an Anti-HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies.
Filip Janku, Sae-Won Han, Toshihiko Doi, Alessio Amatu, Jaffer A Ajani, Ping C Mahling

Cancer Immunol Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Licogliflozin versus placebo in women with polycystic ovary syndrome: A randomized, double-blind, phase 2 trial.
Susanne Tan, Stanislav Ignatenko, Frank Wagner, Anuja Dokras, Jochen Seufert, Ping Mahling

Diabetes Obes Metab· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation and Management of Stool Frequency and Consistency Associated With SGLT1 Inhibition by Reducing Dietary Carbohydrate: A Randomized Trial.
YanLing He, Jül Schofield, Ping Mahling, Anisha E Mendonza, Markus Hinder

Clin Pharmacol Ther· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery disease.
Kerry S Russell, Denise P Yates, Christopher M Kramer, Andrea Feller, Ping Mahling

Vasc Med· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes.
Yan-Ling He, William Haynes, Charles D Meyers, Ahmed Amer, Yiming Zhang, Ping Mahling

Diabetes Obes Metab· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis